NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Ghady Haidar
Conditions: Immuno-Deficiency, COVID-19
Interventions: Evusheld
Countries: United States
This is a study of immunocompromised individuals who have received or plan to receive a drug called EVUSHELD. This study is looking at any serious adverse events that might happen after receiving EVUSHELD, the levels of EVUSHELD in participant's blood, blood antibody levels, neutralizing antibodies against SARS-CoV-2 (the virus that causes COVID-19), and other blood responses related to the immune system and COVID-19. Investigators are collecting blood and may also collect other samples such as nose swabs, oral swabs, or saliva.
Sex: ALL
Age: 12 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Age ≥ 12 and at least 40 kg * Eligible for EVUSHELD as per the EUA Exclusion Criteria: * Active and confirmed COVID-19 * Known or suspected pregnancy, concurrent lactation * Any other significant disease, disorder, or finding, in the opinion of the investigator, that may significantly increase the risk to the participant because of participation in the study, affect the ability of the subject to participate in the study, or impair interpretation of the study data
- Pittsburgh, Pennsylvania, United States